BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $208,172 | -5.2% | 4,569 | -15.6% | 0.01% | 0.0% |
| Q1 2023 | $219,518 | -34.8% | 5,412 | -18.0% | 0.01% | -41.7% |
| Q4 2022 | $336,632 | +6.2% | 6,604 | +12.2% | 0.01% | 0.0% |
| Q3 2022 | $317,000 | -16.6% | 5,888 | -0.4% | 0.01% | -7.7% |
| Q2 2022 | $380,000 | -11.0% | 5,914 | +7.4% | 0.01% | 0.0% |
| Q1 2022 | $427,000 | -9.9% | 5,507 | -0.3% | 0.01% | 0.0% |
| Q4 2021 | $474,000 | -11.4% | 5,521 | -16.9% | 0.01% | -18.8% |
| Q3 2021 | $535,000 | -2.0% | 6,645 | -2.0% | 0.02% | 0.0% |
| Q2 2021 | $546,000 | -7.5% | 6,781 | -3.1% | 0.02% | -15.8% |
| Q1 2021 | $590,000 | -0.8% | 6,995 | -5.6% | 0.02% | -5.0% |
| Q4 2020 | $595,000 | -3.1% | 7,409 | -2.9% | 0.02% | -16.7% |
| Q3 2020 | $614,000 | -11.0% | 7,634 | -4.8% | 0.02% | -20.0% |
| Q2 2020 | $690,000 | +14.6% | 8,016 | +8.0% | 0.03% | -16.7% |
| Q1 2020 | $602,000 | -7.7% | 7,419 | -4.9% | 0.04% | +28.6% |
| Q4 2019 | $652,000 | -4.0% | 7,798 | +0.4% | 0.03% | -15.2% |
| Q3 2019 | $679,000 | +8.3% | 7,765 | +1.4% | 0.03% | +3.1% |
| Q2 2019 | $627,000 | +3.3% | 7,658 | +2.6% | 0.03% | -5.9% |
| Q1 2019 | $607,000 | -7.5% | 7,461 | -25.1% | 0.03% | -29.2% |
| Q4 2018 | $656,000 | -24.9% | 9,959 | -12.2% | 0.05% | -5.9% |
| Q3 2018 | $874,000 | -11.6% | 11,340 | -15.3% | 0.05% | -22.7% |
| Q2 2018 | $989,000 | +43.8% | 13,396 | +26.6% | 0.07% | +32.0% |
| Q1 2018 | $688,000 | -3.8% | 10,583 | -4.3% | 0.05% | -9.1% |
| Q4 2017 | $715,000 | +24.6% | 11,063 | +21.0% | 0.06% | +17.0% |
| Q3 2017 | $574,000 | +10.6% | 9,146 | +6.6% | 0.05% | -4.1% |
| Q2 2017 | $519,000 | +18.0% | 8,576 | +1.2% | 0.05% | +14.0% |
| Q1 2017 | $440,000 | -0.5% | 8,475 | -15.1% | 0.04% | -10.4% |
| Q4 2016 | $442,000 | -5.2% | 9,977 | +1.9% | 0.05% | -12.7% |
| Q3 2016 | $466,000 | 0.0% | 9,790 | -4.9% | 0.06% | -9.8% |
| Q2 2016 | $466,000 | +5.2% | 10,295 | -4.6% | 0.06% | 0.0% |
| Q1 2016 | $443,000 | -12.5% | 10,795 | -18.5% | 0.06% | -14.1% |
| Q4 2015 | $506,000 | +11.2% | 13,252 | -4.3% | 0.07% | -1.4% |
| Q3 2015 | $455,000 | -53.3% | 13,843 | -0.6% | 0.07% | -46.3% |
| Q2 2015 | $974,000 | -10.7% | 13,927 | -12.5% | 0.13% | -7.6% |
| Q1 2015 | $1,091,000 | -44.3% | 15,924 | -40.4% | 0.14% | -44.0% |
| Q4 2014 | $1,958,000 | – | 26,716 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |